BMTCN Test UPDATED ACTUAL Questions and CORRECT Answers
2 views 0 purchase
Module
BMTCN
Institution
BMTCN
BMTCN Test UPDATED ACTUAL
Questions and CORRECT Answers
Which of the following is NOT an identified risk factor associated with infection?
A. Personal history of infection
B. Type of transplantation (autologous or allogeneic)
C. Myeloablative Transplant
D. None of the Above - CORRECT ANSWER-...
BMTCN Test UPDATED ACTUAL
Questions and CORRECT Answers
Which of the following is NOT an identified risk factor associated with infection?
A. Personal history of infection
B. Type of transplantation (autologous or allogeneic)
C. Myeloablative Transplant
D. None of the Above - CORRECT ANSWER✔✔- D. None of the above
Clostridium difficile is not a common infection in the post-transplant setting
A. True
B. False - CORRECT ANSWER✔✔- B. False
A cord blood transplantation is associated with all of the following except:
A. Prolonged neutrophil and immune recovery
B. Increase in viral infections
C. Decrease in bacterial infections
D. Decrease in graft-versus-host disease (GVHD) - CORRECT ANSWER✔✔- C. Decrease
in bacterial infections
Which of the following is true when considering bacterial infections in patients after
transplant?
A. Patients are at a significant risk for encapsulated bacterial infections
B. Multidrug-resistant organisms are not a major concern
C. Streptococcus pneumoniae is not a common post-transplant bacterial infection
D. Immunizations are not effective in controlling post-transplant bacterial or viral infections -
CORRECT ANSWER✔✔- A. Patients are at a significant risk for encapsulated bacterial
infections
The following strategies should be considered in an effort to prevent post-transplant
infectious complications:
1. Immunizations should begin immediately following transplant discharge
,2. Antiviral and anti-fungal prophylaxis medications should be considered in the post-
transplant setting
3. Lifestyle restrictions vary in each transplant center and often are enforced to decrease post-
transplant infections. It is important to communicate lifestyle expectations and restrictions to
patients and their families
4. Measles, mumps, and rubella immunization should be administered at 12 months
A. 1, 2, 3, 4,
B. 2 and 3
C. 2 and 4
D. 2, 3, 4 - CORRECT ANSWER✔✔- B. 2 and 3
Cardiovascular disease may be underreported in hematopoietic stem cell transplant (HSCT)
recipients because symptoms may occur several months to several years following HSCT
A. True
B. False - CORRECT ANSWER✔✔- A. True
Which risk factors are associated with post-HSCT cardiovascular disease? 1) Hypertension,
2)Gender, 3)Certain immunosuppressive medications, 4) Previous anthracycline
chemotherapy
A. 1, 2, 3, 4
B. 1, 3, 4
C. 2, 3, 4
D. 1, 2, 3 - CORRECT ANSWER✔✔- B. 1, 3, 4
The following strategies are used to manage cardiovascular disease in post HSCT patients
EXCEPT:
A. Antihypertensive medications
B. Statin therapy
C. Dietary counseling
D. Prophylactic anti fungal medications - CORRECT ANSWER✔✔- D. Prophylactic anti-
fungal medications
, Patients should be monitored for the clinical signs and symptoms of cardiac disease post-
HSCT by which of the following?
A. Annual clinical assessment that includes baseline vital signs, review of symptoms, and
physical examination
B. Careful attention to travel over the last year
C. Lifestyle counseling about smoking cessation, weight management, and stress reduction
D. All of the above except B
E. All of the above except C - CORRECT ANSWER✔✔- D. all of the above except B
Which of the following chemotherapy agents is associated with patients cardiac disease in the
post-HSCT setting?
A. Bendamustine
B. Melphalan
C. Doxorubicin
D. Methotrexate - CORRECT ANSWER✔✔- C. Doxorubicin
Graft failure or graft rejection is associated with all of the following EXCEPT:
A. Incidence of 1%-20%
B. Favorable prognosis
C. Loss of donor cells after initial engraftment
D. Potential for marrow aplasia and pancytopenia - CORRECT ANSWER✔✔- B. Favorable
prognosis
Graft failure may result from which of the following
A. Type of primary disease
B. Human leukocyte antigen (HLA) disparity
C. Immunosuppression
D. GVHD
E. All of the above - CORRECT ANSWER✔✔- E. All of the above
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller MGRADES. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for £8.88. You're not tied to anything after your purchase.
